Mei Pharma Inc (MEIP)

Dec 17, 2024

MEI Pharma (NASDAQ:MEIP) Earns Buy Rating from Analysts at StockNews.com - Defense World

Dec 17, 2024

Dec 16, 2024

MEI Pharma stock hits 52-week low at $2.54 amid market challenges - Investing.com Australia

Dec 16, 2024

Dec 16, 2024

MEI Pharma stock hits 52-week low at $2.54 amid market challenges By Investing.com - Investing.com South Africa

Dec 16, 2024

Dec 05, 2024

MEI Pharma (LTS:0JW9) 5-Day RSI : 36.09 (As of Dec. 05, 2024) - GuruFocus.com

Dec 05, 2024

Nov 30, 2024

MEIP (MEI Pharma) Financial Strength : 7 (As of Sep. 2024) - GuruFocus.com

Nov 30, 2024

Nov 29, 2024

Follicular Lymphoma Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Malaysian Reserve

Nov 29, 2024

Nov 27, 2024

MEI Pharma (LTS:0JW9) Total Inventories : $0.00 Mil (As of Sep. 2024) - GuruFocus.com

Nov 27, 2024

Nov 13, 2024

MEI Pharma Reports Strategic Shift Amid Financial Losses - TipRanks

Nov 13, 2024

Nov 12, 2024

MEI Pharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024

Nov 12, 2024

MEI Pharma reports Q1 EPS ($1.20) vs. $8.46 last year - TipRanks

Nov 12, 2024

Nov 12, 2024

MEI Pharma Explores Strategic Sale Amid Cash Preservation Efforts, Reports $26.9M Cash Position | MEIP Stock News - StockTitan

Nov 12, 2024

Nov 08, 2024

Acute Myeloid Leukemia (AML) Treatment Market in APAC to Grow by USD 305.8 Million from 2024-2028, Driven by High Incidence and AI-Driven Market TransformationTechnavio - The Malaysian Reserve

Nov 08, 2024

Oct 31, 2024

Layoff Tracker: Compass Pathways to Lay Off 30% of Employees - BioSpace

Oct 31, 2024

Oct 28, 2024

Pre-market Movers: EVOK, HCTI, GLUE, MNPR... - RTTNews

Oct 28, 2024

Oct 28, 2024

Aardvark Therapeutics, Inc. agreed to acquire rights, title and interest in and to certain assets related to ME-344 from MEI Pharma, Inc. for $62.5 million. - Marketscreener.com

Oct 28, 2024

Oct 27, 2024

Data Readouts At EHA Congress 2021 (APTO, XFOR, GBT, CRIS…) - RTTNews

Oct 27, 2024

Oct 25, 2024

Stocks to Watch: MEI Pharma, Hawaiian Electric Industries - MarketWatch

Oct 25, 2024

Oct 25, 2024

MEI Shares Rise After Entering Asset Purchase Agreement Valued at Up to $62 Million - MarketWatch

Oct 25, 2024

Oct 25, 2024

MEI Pharma postpones special meeting to vote on Infinity deal until July 23 - MSN

Oct 25, 2024

Oct 24, 2024

MEIP (MEI Pharma) Free Cash Flow per Share : $-7.57 (TTM As of Jun. 2024) - GuruFocus.com

Oct 24, 2024

Oct 22, 2024

Post Polycythemia Vera Myelofibrosis Market: Holistic - openPR

Oct 22, 2024

Oct 14, 2024

Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated by Analysts at StockNews.com - Defense World

Oct 14, 2024

Oct 09, 2024

MEI Pharma stock hits 52-week low at $2.72 amid market challenges - Investing.com India

Oct 09, 2024

Oct 08, 2024

MEI Pharma stock hits 52-week low at $2.72 amid market challenges By Investing.com - Investing.com South Africa

Oct 08, 2024

Oct 01, 2024

Acute Myeloid Leukemia Market Trends, Key Drivers, Opportunities, Leading Players And Forecast To 2033 - WhaTech

Oct 01, 2024

Sep 25, 2024

Histone Deacetylase 2 Industry Forecast (2024-2034) Under Inflation - Apiculture Market: Report ...

Sep 25, 2024

Sep 23, 2024

Myelodysplastic Syndrome Drugs Market Research Explores Size, Market Competitive Landscape, Business Growth... - WhaTech

Sep 23, 2024

Sep 22, 2024

Chronic Lymphocytic Leukemia Treatment Market Advancements Highlighted by Comprehensive Analysis, Advanceme... - WhaTech

Sep 22, 2024

Sep 20, 2024

Follicular Lymphoma Treatment Market Insights Discussed Regarding Size, Trends, and Overview Report 2024-2033 - WhaTech

Sep 20, 2024

Sep 20, 2024

MEI Pharma reviews strategic options amid fiscal changes - Investing.com India

Sep 20, 2024

Sep 19, 2024

MEI Pharma confirms continuation of evaluation of strategic alternatives - TipRanks

Sep 19, 2024

Sep 19, 2024

MEI Pharma Reports Fiscal Year End 2024 Cash Position - The Bakersfield Californian

Sep 19, 2024

Sep 16, 2024

Expanding the Bispecific Antibody Market from CAR-Ts to Drive Follicular Lymphoma's Future | DelveInsight - PR Newswire UK

Sep 16, 2024

Sep 15, 2024

LPL Financial (NASDAQ:LPLA) Research Coverage Started at Wells Fargo & Company - Defense World

Sep 15, 2024

Sep 15, 2024

Los Angeles Capital Management LLC Reduces Stake in Martin Marietta Materials, Inc. (NYSE:MLM) - Defense World

Sep 15, 2024

Sep 05, 2024

Mei Pharma announces exclusive license agreement with Presage Biosciences for voruciclib - Reuters

Sep 05, 2024

Sep 02, 2024

Histone Deacetylase Inhibitors Report 2024, Industry Analysis And Overview By 2033 - WhaTech

Sep 02, 2024

Aug 23, 2024

Post-Polycythemia Vera Myelofibrosis (PPV-MF) Industry - openPR

Aug 23, 2024

Aug 22, 2024

Helsinn Investment Fund reports 7.1 pct passive stake in MEI PharmaSEC filing - Reuters

Aug 22, 2024

Aug 17, 2024

MEIP (MEI Pharma) Dividends per Share : $0.00 (TTM As of Mar. 2024) - GuruFocus.com

Aug 17, 2024

Aug 16, 2024

Rx Rundown: Vantive, Gilead Sciences, Halda Therapeutics and more - MM+M Online

Aug 16, 2024

Aug 12, 2024

MEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic Alternatives - StockTitan

Aug 12, 2024

Aug 11, 2024

StockNews.com Initiates Coverage on MEI Pharma (NASDAQ:MEIP) - Defense World

Aug 11, 2024

Aug 07, 2024

GreenWood Investors First Half 2024 Letter - Seeking Alpha

Aug 07, 2024

Aug 05, 2024

MEI Pharma (MEIP) – Research Analysts’ Recent Ratings Updates - Defense World

Aug 05, 2024

Aug 05, 2024

Game-Changing BCL-2 Inhibitors Set to Revolutionize Cancer Treatment Market | DelveInsight - GlobeNewswire

Aug 05, 2024

Aug 03, 2024

MEI Pharma announces executive departures and strategic shifts - Investing.com

Aug 03, 2024

Aug 02, 2024

MEI Pharma announces executive departures and strategic shifts By Investing.com - Investing.com Canada

Aug 02, 2024

Aug 02, 2024

MEI Pharma Explores Strategic Shifts, Leadership Changes - TipRanks

Aug 02, 2024